Equity Research, Broker Reports, and media content on Redx Pharma

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Redx Pharma
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Redx Pharma. We currently have 72 research reports from 5 professional analysts.

Open
N/A
Range Today
N/A
52 Week
5.05/13.0p
Daily Volume
N/A
# Shares
126.5m
Daily Liquidity
(0.02%)
Pension Liability
£0m
Enterprise Value
£1.88m
Market Cap
£10.8m
Latest PE (hist)
Div Yield
Date Source Announcement
19Aug19 07:00 RNS First cohort of patients dosed in RXC004 study
18Jul19 10:24 EQS Hardman & Co Research: RedX Pharma (REDX): Pan-RAF agreement strengthens balance sheet
11Jul19 13:41 EQS Hardman & Co Research: Redx Pharma (REDX): Phase I trial resumed
10Jul19 07:00 RNS Sale of pan-RAF inhibitor programme
10Jun19 07:01 RNS Interim Results for six months ended 31 March 2019
10Jun19 07:00 RNS Short-term Debt Funding Secured
03May19 11:34 RNS Update on Plans to Strengthen Balance Sheet
  • Frequency of research reports

     

  • Research reports on

    Redx Pharma

  • Providers covering

    Redx Pharma